Abstract
Objectives To identify COVID-19 outbreaks and border control failures associated with quarantine systems in Australia and New Zealand and to estimate the failure risks.
Design, setting, participants Observational epidemiological study of travellers transiting quarantine in Australia and New Zealand up to 15 June 2021.
Main outcome measures The incidence of COVID-19 related failures arising from quarantine, and the failure risk for those transiting quarantine, estimated both per 100,000 travellers and per 1000 SARS-CoV-2 positive cases.
Results Australia and New Zealand had 32 COVID-19 related failures arising from quarantine systems up to 15 June 2021 (22 and 10, respectively). One resultant outbreak involved an estimated 800 deaths and quarantine failures instigated nine lockdowns. The failure risk for those transiting quarantine was estimated at 5.0 failures per 100,000 travellers and 6.1 failures (95%CI: 4.0 to 8.3) per 1000 SARS-CoV-2 positive cases. The latter risk was two-fold higher in New Zealand compared with Australia. The full vaccination of frontline border workers could likely have prevented a number of quarantine system failures.
Conclusions Quarantine system failures can be costly in terms of lives and economic impacts such as lockdowns. Ongoing improvements or alternatives to hotel-based quarantine are required.
Introduction
New Zealand and Australian states have successfully eliminated community transmission of the pandemic virus ‘severe acute respiratory syndrome coronavirus 2’ (SARS-CoV-2),1 albeit with occasional outbreaks from imported cases that have typically been quickly brought under control. These two countries have primarily used hotel-based quarantine for citizens returning to their countries during the pandemic period, with 14 days of quarantine combined with polymerase chain reaction (PCR) testing and mask use in any shared spaces (eg, common exercise areas used in New Zealand, but not in most Australian states).
Converting hotels for quarantine purposes has the advantage of making use of a resource that would otherwise be underused during a pandemic, given declines in international tourism. However, the major disadvantage of hotel-based quarantine is that it is likely to be less effective than purpose-built quarantine facilities owing to shared spaces and lack of safe ventilation (as per World Health Organization advice on air flow2). Moreover, the consequences of leakage of the virus out of quarantine (eg, through facility workers) may be more severe given higher population density in urban settings where the hotels are located. Given these issues, we aimed to estimate the failure risk of quarantine systems in New Zealand and Australia in terms of the spread of ‘coronavirus disease 2019’ (COVID-19) infection into the community.
As of 13 June 2021, the rolling 7-day average number of COVID-19 vaccine doses administrated per 100 people was 0.46 in Australia and 0.31 in New Zealand.3 However, this was counted as single vaccine doses and does not equal the total number of people vaccinated (eg, the Pfizer/BioNTech vaccine which is currently used in New Zealand requires two doses).3 The majority of border workers in Australia and New Zealand have been vaccinated (eg, in New Zealand over 56,000 doses had been administered to border workers as of 28 March 2021,4 and all hotel quarantine workers in Victoria who have face-to-face contact with returned travellers received their first dose of the vaccine by the first week in April 20215).
Methods
We defined a quarantine system failure as where a border/health worker or person in the community with a link to the quarantine/isolation system, became infected with SARS-CoV-2. This definition included people infected in hospital from cases who had been transferred from a quarantine facility (as such cases were still in the 14-day quarantine process), but did not include pandemic virus transmission between returnees within the quarantine facilities.
We searched official websites in both countries, and for the eight states and territories in Australia, to identify outbreaks and border control failures associated with quarantine systems (searches conducted between 6 January and 23 June 2021). Where an outbreak source was uncertain (eg, the Auckland, New Zealand, August 2020 outbreak) we used the best available evidence to classify it as a quarantine failure or not. The decision to label an incident as a quarantine system failure was confirmed by all co-authors. We used two denominators: a) the estimated number of travellers who went through quarantine facilities during the 2020 year (data were for the period starting 1 April 2020 for Australia and 17 June 2020 for New Zealand) up to 15 June 2021; and b) the number of SARS-CoV-2 positive people who went through these facilities in this same time period. The unit of analyses were New Zealand, the eight Australian states and territories, and both countries combined.
For New Zealand, we used official data on both travellers going through the quarantine system6 along with official (Ministry of Health) data on SARS-CoV-2 positive cases,7 although there are some discrepancies in the information about when regular testing began in Managed Isolation and Quarantine (MIQ) facilities. For Australia we used overseas arrival data8 and health data.9, 10
Results
The collated data for quarantine system failures are shown in Table 1, with specific details of each event in the Appendix (Table A1). In Australia, 22 failures were identified, one resultant outbreak caused over 800 deaths (Victoria’s second wave) and with eight lockdowns linked to quarantine system failures. In New Zealand, there were ten failures, with one causing an outbreak with three deaths, and also a lockdown.
Given our estimates of the number of travellers processed via quarantine systems (Table 1), the overall risks for both countries combined were one failure per 20,156 travellers, and one failure per 163 SARS-CoV-2 positive cases in quarantine. The combined data can also be interpreted as quarantine system failures leading to a lockdown response per 71,665 travellers; and approximately one death from COVID-19 per 803 travellers (using the 800 deaths estimate from Australia and the three deaths from New Zealand – although this figure is largely driven by the second wave in Victoria and is unlikely generalizable forward in time).
At the country level, there were 10.5 failures per 1000 SARS-CoV-2 positive cases transiting quarantine in New Zealand (95% confidence interval [CI]: 4.0 to 17.0), compared to 5.2 per 1000 SARS-CoV-2 positive cases in Australia (95%CI: 3.0 to 7.3) – a two-fold difference in risk (relative risk: 2.0, 95%CI: 1.0 to 4.2). The full vaccination of frontline border workers (Table A1) could likely have prevented a number of quarantine system failures due to the combined effects of vaccination lowering the risk of getting infected by 70% (as in the case of the Moderna vaccine11) or more (eg, the Pfizer/BioNTech vaccine is approximately 95% effective at preventing SARS-CoV-2 infection for wild-type and Beta variants for adults 16 years of age or older13), and the lesser duration of infectivity and lower peak infectivity for those infected.12
Discussion
This analysis identified 32 failures of quarantine systems in Australia and New Zealand combined (up to 15 June 2021). The relatively higher failure risk per 1000 SARS-CoV-2 positive cases transiting quarantine in New Zealand versus Australia could reflect a lower quality approach in the former, with perhaps some of the difference due to greater detection in New Zealand from more border worker testing over a longer period.
These estimates are subject to chance variations due to the low numbers of failures. These estimates will also probably be an underestimate of all quarantine system failures, as not all of those infected will transmit the virus and start a detectable chain of transmission. Genomes of the first 649 viral isolates collected in New Zealand show that only 19% of virus introductions resulted in ongoing transmission of more than one additional case.14 Therefore, counts of border system failures are sensitive to how they are identified and defined. Indeed, with increased testing (eg, testing of people after leaving quarantine on day 16 as is now common in Australia), we may be detecting failures that previously would have been undetected.
Looking forward, the failure risks per month in New Zealand and Australia may increase, given that the proportion of travellers returning to these countries who are infected is increasing due to global intensification of the pandemic and the increasing infectivity of new SARS-CoV-2 variants.15 Indeed, there have been several clearly documented cases of spread within quarantine hotels (eg, two instances in Melbourne in February 2021, two instances in Sydney in April 2021, and one in South Australia in May 2021), highlighting the increased risk and evolving situation with more highly infectious variants arriving from overseas.
However, offsetting this trend will be measures such as the vaccination of quarantine workers. In New Zealand, the vaccination of border workers began in February 2021 with the Pfizer/BioNTech vaccine. However, vaccination does not fully protect against SARS-CoV-2 transmission, although a moderate degree of protection is likely. For example, infection rates were halved for the AstraZeneca vaccine,16, 17 reduced by 70% for the Moderna mRNA vaccine as indicated by using swab results for asymptomatic infection plus symptomatic cases,11 and reduced by 95% for the Pfizer/BioNTech mRNA vaccine as indicated by national surveillance data in Israel.13 For vaccinated people who are infected, primate study evidence suggests (consistent with expectation) that the infectivity is decreased in peak and duration,12 further protecting the border.
Furthermore, the level of testing of quarantine workers has been increasing (eg,18; which will find some failures before they have a chance to establish as an outbreak in the community). There have been other improvements in the quarantine systems over time (eg, improved security, introduction of mask wearing within quarantine settings, reduction in shared spaces, improved personal protective equipment (PPE) used by workers, and other procedures as detailed in both countries19, 20).
Another risk reduction practice would be using better or purpose-built facilities in rural locations as these have less risk from close contacts in central business district hotels and within-building spread from poor ventilation systems. To date, there have been no failures at the Howard Springs facility outside of Darwin, and the success of the facility was cited in the announcement in June 2021 of the construction of a new purpose-built quarantine facility in Victoria.21 Other infection prevention and control measures (eg, PPE) will remain important in all quarantine facilities.
Limitations of our analysis include residual uncertainty around the cause of some outbreaks (eg, the Auckland one in August 2020), and imprecision with denominator data on traveller numbers for Australia (eg, some travellers were moved between states on domestic flights which is not captured in the official data we used). Additionally, case numbers are constantly changing, due to the number of reclassifications caused by false positives and duplications. We also did not assess the change in the quarantine system failures over time due to the relatively small number of failure events. The risk of system failures is probably highly dynamic on a month-by-month basis as traveller volumes, infection rates, and quarantine processes change, and as vaccination rates among border workers and in the wider community increase.
To substantially reduce the risk of SARS-CoV-2 incursion out of quarantine (until such time as enough of the population is vaccinated), the most obvious action is to reduce arrivals, or even suspend arrivals, from high infection locations (as New Zealand and Australia temporarily did for travel from India and other high risk countries in April 202122). Beyond this, there are a range of other potential improvements in ongoing arrangements and processes as detailed in Table 2. Furthermore, the start of quarantine-free travel between Australia and New Zealand (also known as a “green zone”) in April 2021 provides an opportunity to benchmark COVID-19 border control policies and practices, identify potential improvements in both countries, and harmonise best practices across the region. The green zone further intertwines the biosecurity status of both nations and it is therefore even more important to lower the risk of border failures that could disrupt such travel. This shift from a one-size-fits-all strategy to a risk-based approach to border management can be summarised as a ‘traffic light’ approach.23
Conclusions
In summary, Australia and New Zealand have had 32 COVID-19 identified failures arising from quarantine systems up to 15 June 2021. Quarantine system failures can be costly in terms of lives and economic impacts such as lockdowns. Ongoing improvements or alternatives to hotel-based quarantine are required.
Data Availability
The datasets analyzed during the current study were derived from public resources available from the New Zealand Ministry of Business Innovation & Employment, the New Zealand Ministry of Health. the Australia Bureau of Statistics. and the Australian Department of Health.
https://www.health.gov.au/resources/collections/coronavirus-covid-19-common-operating-picture
Competing interests
Nil.
Funding
Prof Baker and Dr Kvalsvig received funding support from the Health Research Council of New Zealand (20/1066). Dr Grout, Ms Katar, Dr Ait Ouakrim, Dr Summers, Prof Blakely, and Prof Wilson did not have external funding support.
Appendix
Footnotes
The data in this manuscript have been updated through 15 June 2021. Some of the text has been revised to reflect updated estimates. We have deleted some information that is now out-of-date, including Appendix Table 2.
References
